Vilsboll T, Lindahl CO, Nielsen NF, Tikkanen CK, et al. Real-world impact of once-weekly subcutaneous semaglutide after two years of follow-up: Results from a nationwide observational study in people with type 2 diabetes. Diabetes Obes Metab 2023 Feb 21. doi: 10.1111/dom.15031.
PMID: 36809678